WithdrawnEarly Phase 1NCT00829608

Therapeutic Treatment With Human Papillomavirus Quadrivalent Vaccine for Recurrent Respiratory Papillomatosis

Studying Recurrent respiratory papillomatosis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University of Missouri-Columbia
Principal Investigator
Troy D Scheidt, MD
University of Missour-Columbia
Intervention
Human Papillomavirus Vaccine(biological)
Eligibility
18-80 years · All sexes
Timeline
2009 – 2010

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00829608 on ClinicalTrials.gov

Other trials for Recurrent respiratory papillomatosis

Additional recruiting or active studies for the same condition.

See all trials for Recurrent respiratory papillomatosis →

← Back to all trials